{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:33:01Z","timestamp":1783470781363,"version":"3.55.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157242","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T17:34:24Z","timestamp":1466184864000},"page":"e0157242","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites"],"prefix":"10.1371","volume":"11","author":[{"given":"Bonita","family":"Durna\u015b","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Wnorowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pogoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Deptu\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"W\u0105tek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Piktel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"G\u0142uszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Niemirowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,17]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"D Bitar","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"S Silva","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.aambs.2014.12.002","article-title":"Candida survival strategies","volume":"91","author":"M Polke","year":"2015","journal-title":"Adv Appl Microbiol"},{"issue":"3","key":"ref4","first-page":"211","article-title":"Predisposing factors endorsing Candida infections","volume":"23","author":"S Singh","year":"2015","journal-title":"Infez Med"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","article-title":"Virulence factors of Candida albicans","volume":"9","author":"RA Calderone","year":"2001","journal-title":"Trends in microbiology"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.mib.2011.06.001","article-title":"Mucosal biofilms of Candida albicans","volume":"14","author":"S Ganguly","year":"2011","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tim.2011.07.004","article-title":"Importance of Candida-bacterial polymicrobial biofilms in disease","volume":"19","author":"MM Harriott","year":"2011","journal-title":"Trends Microbiol"},{"issue":"4","key":"ref8","first-page":"163","article-title":"Characteristics of biofilm formation by Candida albicans","volume":"18","author":"G Ramage","year":"2001","journal-title":"Rev Iberoam Micol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00294-013-0400-3","article-title":"Recent insights into Candida albicans biofilm resistance mechanisms","volume":"59","author":"L Math\u00e9","year":"2013","journal-title":"Curr Genet"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"HT Taff","year":"2013","journal-title":"Future Microbiol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4248\/IJOS11022","article-title":"The role of bacterial biofilm in persistent infections and control strategies","volume":"3","author":"L Chen","year":"2011","journal-title":"Int J Oral Sci"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"HC Flemming","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1128\/AEM.71.9.5404-5410.2005","article-title":"Extracellular DNA in single- and multiple-species unsaturated biofilms","volume":"71","author":"RE Steinberger","year":"2005","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/jam.12483","article-title":"Effects of extracellular DNA from Candida albicans and pneumonia-related pathogens on Candida biofilm formation and hyphal transformation","volume":"116","author":"B Sapaar","year":"2014","journal-title":"J Appl Microbiol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.00471-08","article-title":"Effect of DNase and antibiotics on biofilm characteristics","volume":"53","author":"GV Tetz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.coph.2012.06.006","article-title":"New horizons for host defense peptides and lantibiotics","volume":"12","author":"MJ Dawson","year":"2012","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1189\/jlb.0609382","article-title":"Human defensins and LL-37 in mucosal immunity","volume":"87","author":"M Doss","year":"2010","journal-title":"J Leukoc Biol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00005-009-0057-2","article-title":"Cathelicidin LL-37: a multitask antimicrobial peptide","volume":"58","author":"R Bucki","year":"2010","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4236\/abb.2011.26059","article-title":"Degradation of naturally occurring and engineered antimicrobial peptides by proteases","volume":"2","author":"BJ Moncla","year":"2011","journal-title":"Adv Biosci Biotechnol"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph6081055","article-title":"Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics","volume":"6","author":"W Aoki","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11448.x","article-title":"Antibacterial properties of cationic steroid antibiotics","volume":"217","author":"PB Savage","year":"2002","journal-title":"FEMS Microbiol Lett"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.bbamem.2007.05.023","article-title":"Bacterial lipid composition and the antimicrobial efficacy of cationic steroid compounds (Ceragenins)","volume":"1768","author":"RF Epand","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/AAC.00380-10","article-title":"Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins","volume":"54","author":"RF Epand","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/AAC.01325-06","article-title":"Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus","volume":"51","author":"JN Chin","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkm457","article-title":"Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa","volume":"61","author":"JN Chin","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/jac\/dks434","article-title":"Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections","volume":"68","author":"K Leszczynska","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1645\/GE-2329.1","article-title":"Anti-trypanosomatid activity of ceragenins","volume":"96","author":"D Lara","year":"2010","journal-title":"J Parasitol"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1038\/jid.2009.120","article-title":"Ceragenins: a class of antiviral compounds to treat orthopox infections","volume":"129","author":"MD Howell","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.08.003","article-title":"CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates","volume":"46","author":"X Vila-Farr\u00e9s","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"ref30","first-page":"999","article-title":"MBI-226. Micrologix\/Fujisawa","volume":"4","author":"RE Isaacson","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.48.8.3112-3118.2004","article-title":"Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity","volume":"48","author":"HS Sader","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","unstructured":"A service of the U.S. National Institutes of Health. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/<\/ext-link>."},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/jm0105070","article-title":"Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics","volume":"45","author":"B Ding","year":"2002","journal-title":"J Med Chem"},{"key":"ref34","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd ed. CLSI document M27-A3.2008."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1166\/jbn.2013.1542","article-title":"Dye-doped silica nanoparticle with HIV-1 TAT peptide for bioimaging","volume":"9","author":"JH Choi","year":"2013","journal-title":"J Biomed Nanotechnol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"e86364","DOI":"10.1371\/journal.pone.0086364","article-title":"Antimicrobial properties and membrane-active mechanism of a potential \u03b1-helical antimicrobial derived from cathelicidin PMAP-36","volume":"9","author":"Y Lv","year":"2014","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12866-015-0457-x","article-title":"Polyelectrolyte-mediated increase of biofilm mass formation","volume":"15","author":"R Bucki","year":"2015","journal-title":"BMC microbiology"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.00134-06","article-title":"Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes","volume":"50","author":"R Bucki","year":"2006","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"e28176","DOI":"10.1371\/journal.pone.0028176","article-title":"Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agents","volume":"6","author":"KS Kim","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dna.2009.1011","article-title":"Effect of extracellular DNA destruction by DNase I on characteristics of forming biofilms","volume":"29","author":"VV Tetz","year":"2010","journal-title":"DNA Cell Biol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.01998-13","article-title":"Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain","volume":"51","author":"M Bassetti","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2672.2010.04874.x","article-title":"Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections","volume":"110","author":"K Leszczy\u0144ska","year":"2011","journal-title":"J Appl Microbiol"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/AAC.02642-13","article-title":"Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide","volume":"58","author":"M Garc\u00eda-Quintanilla","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1128\/AAC.02554-14","article-title":"LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents","volume":"58","author":"EM Haisma","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 2","key":"ref45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BJ20042099","article-title":"Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane","volume":"388","author":"AL den Hertog","year":"2005","journal-title":"Biochem J"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12275-014-3630-2","article-title":"Responses of Candida albicans to the human antimicrobial peptide LL-37","volume":"52","author":"PW Tsai","year":"2014","journal-title":"J Microbiol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dkl382","article-title":"Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts","volume":"58","author":"M Benincasa","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jac\/dkn176","article-title":"Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13","volume":"62","author":"R Bucki","year":"2008","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.3390\/s131012943","article-title":"Degradation of bacterial quorum sensing signaling molecules by the microscopic yeast Trichosporon loubieri isolated from tropical wetland waters","volume":"13","author":"CS Wong","year":"2013","journal-title":"Sensors (Basel)"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1469-0691.12440","article-title":"Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland","volume":"20","author":"C Orasch","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/JCM.02363-09","article-title":"Antifungal susceptibility testing of Candida isolates from the Candida surveillance study","volume":"48","author":"GM Lyon","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"Pt 12","key":"ref52","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1099\/jmm.0.075507-0","article-title":"In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates","volume":"63","author":"MT Montagna","year":"2014","journal-title":"J Med Microbiol"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.01475-07","article-title":"Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections","volume":"52","author":"TR Fritsche","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.01670-13","article-title":"Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging","volume":"58","author":"SR Ordonez","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.55.1.2","article-title":"Mechanisms of antimicrobial peptide action and resistance","volume":"55","author":"MR Yeaman","year":"2003","journal-title":"Pharmacol Rev"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/AAC.02738-14","article-title":"Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms","volume":"58","author":"M Guembe","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11046-009-9264-y","article-title":"Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms","volume":"169","author":"M Martins","year":"2010","journal-title":"Mycopathologia"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000339961","article-title":"Extracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity","volume":"5","author":"EA Jones","year":"2013","journal-title":"J Innate Immun"},{"issue":"Pt 4","key":"ref59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1099\/jmm.0.005728-0","article-title":"Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy","volume":"58","author":"QM Parks","year":"2009","journal-title":"J Med Microbiol"},{"issue":"7","key":"ref60","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1128\/AAC.00421-15","article-title":"Bactericidal activity of cathelicidin LL-37 and select cationic lipids against the hypervirulent P. aeruginosa strain LESB58","volume":"59","author":"U Wnorowska","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/jac\/dki460","article-title":"Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids","volume":"57","author":"W Baranska-Rybak","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/IAI.00023-15","article-title":"Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans","volume":"83","author":"M Rapala-Kozik","year":"2015","journal-title":"Infect Immun"},{"issue":"9","key":"ref63","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"UH D\u00fcrr","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-015-0093-5","article-title":"Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles","volume":"13","author":"K Niemirowicz","year":"2015","journal-title":"J Nanobiotechnology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T22:08:53Z","timestamp":1568066933000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157242"}},"subtitle":[],"editor":[{"given":"Joy","family":"Sturtevant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,17]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157242","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,17]]}}}